Publication | Open Access

Distinct effects of human glioblastoma immunoregulatory molecules programmed cell death ligand-1 (PDL-1) and indoleamine 2,3-dioxygenase (IDO) on tumour-specific T cell functions

Neuro-oncologyCancer ImmunosurveillanceGliomaMedicineApoptosisImmunologyCell DeathDistinct EffectsAnti-cancer AgentImmunotherapyCell Death Ligand-1Cell BiologyTumor Microenvironment